97. 潰瘍性大腸炎 Ulcerative colitis Clinical trials / Disease details
臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05753267 (ClinicalTrials.gov) | February 28, 2023 | 22/2/2023 | Fenofibrate in Ulcerative Colitis | Clinical Study to Evaluate the Possible Efficacy of Fenofibrate in Patient With Ulcerative Colitis | Inflammatory Bowel Diseases | Drug: Mesalamine;Drug: Fenofibrate 160mg | Tanta University | Eman Ibrahim Elberri, Faculty of Pharmacy, Tanta University;Hend El-Said Abo Mansour, Faculty of Pharmacy, Menoufia University;Monir Hussein Bahgat, Faculty of Medicine, Mansura University;Eman Maamoun Ali El-Khateeb, Lecturer of Clinical Pharmacy, Faculty of Pharmacy, Tanta University | Recruiting | 18 Years | 75 Years | All | 60 | Phase 2/Phase 3 | Egypt |